Principal Investigator
Danielle Shpiner
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20221012
Clinical Trial Summary
A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinsons Disease
Phase
TBD
Funding Agency/Sponsor
Intramural
Disease
Other